SM
Sikha Mondal
About Sikha Mondal
Data last updated:
Sikha Mondal is a Director at Sunorisys Private Limited (since 2025) and Director at Curevolve Pharma Private Limited (since 2024). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sunorisys Private Limited U46497WB2025PTC281442 | Director | 28 Jul 2025 | 2025 | Active | |
| Curevolve Pharma Private Limited U46497WB2024PTC273496 | Director | 16 Sep 2024 | 2024 | Active |
Board colleagues of Sikha Mondal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dweepshekhar Chatterjee | 10777704 | Sunorisys Private Limited , Curevolve Pharma Private Limited | Director |
| Md Nayeem | 10777705 | Curevolve Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sikha Mondal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sikha Mondal
Sikha Mondal currently holds 2 directorships: Sunorisys Private Limited (Director, since 28 Jul 2025); Curevolve Pharma Private Limited (Director, since 16 Sep 2024).
Sikha Mondal was first appointed on 16 Sep 2024 as Director at Curevolve Pharma Private Limited. The most recent appointment on record is 28 Jul 2025 at Sunorisys Private Limited.
The current boards of Sikha Mondal's companies include Dweepshekhar Chatterjee (Sunorisys Private Limited), Md Nayeem (Curevolve Pharma Private Limited).